However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety
[unverified no linkable source] UK laboratory quality and MHRA medicinal-products framework context (ICH Q7 / ISO 9001 alignment)
For people using GLP-1 drugs for weight loss, 45% plan to use them long-term, but more (51%) are likely to go on and off based on their needs
Comparing individuals on GLP-1 drugs to those on other antidiabetic drugs, results showed that the former had a decreased probability of receiving a new glaucoma diagnosis, wrote the authors of this meta-analysis
[2,5] Semaglutide may also be involved in several brain pathways that regulate appetite and food intake.[2] When Does Semaglutide Start Working
This may be a skewed population, and it would be helpful to see more multi-center studies looking at a broader population
